jcm-logo

Journal Browser

Journal Browser

Clinical Role of Neuroinflammation in Disease

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Immunology".

Deadline for manuscript submissions: closed (10 April 2025) | Viewed by 1842

Special Issue Editor


E-Mail Website
Guest Editor
1. Department of Biochemistry, Faculty of Medicine & Dentistry, University of Alberta, 113 Street 87 Avenue, Edmonton, AB T6G 2E1, Canada
2. Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, 113 Street 87 Avenue, Edmonton, AB T6G 2E1, Canada
3. Department of Oncology, Faculty of Medicine & Dentistry, University of Alberta, 113 Street 87 Avenue, Edmonton, AB T6G 2E1, Canada
4. BioImmuno Designs, 4747 154 Avenue, Edmonton, AB T5Y 0C2, Canada
Interests: inflammation; cancer; drug discovery
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Neuroinflammation is defined as the inflammation of brain tissues. It is activated in response to many signals and helps to protect the brain tissues from injury. Primary abnormalities that arise because of the presence of neuroinflammation in the brain include Parkinson’s Disease, Alzheimer’s Disease (AD), multiple sclerosis, amyotrophic lateral sclerosis (ALS) and encephalitis, to mention but a few. In addition, it is well documented that persistent neuroinflammation in traumatic brain injury can lead to neurological disorders such as epilepsy, encephalopathy and AD. In the past ten years, systemic inflammation (and specifically colonic inflammation) has been demonstrated to promote neuroinflammation in the well-known concept of the “gut–brain axis”. Lastly, autoimmune disorders can also trigger neuroinflammation, resulting in several co-morbidities linked to brain inflammation.

Specific therapeutics to control systemic inflammation are varied and lacking for neuroinflammation. We are only just beginning to understand the molecular drivers of inflammation (systemic and neuronal inflammation), how they are linked to altered metabolism and proliferation and what biomarkers are important in tracking the appearance and progression of inflammation. This Special Issue will illustrate original work and reviews describing the molecular details of neuroinflammation, emerging therapeutic interventions and potential clinical use, with the aim of expanding our understanding of neuroinflammation.

Dr. Shairaz Baksh
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neuroinflammation
  • brain tissues
  • Parkinson's Disease
  • Alzheimer's Disease
  • multiple sclerosis
  • amyotrophic lateral sclerosis
  • encephalitis
  • traumatic brain injury
  • epilepsy
  • encephalopathy
  • systemic inflammation
  • colonic inflammation
  • gut-brain axis
  • autoimmune disorders
  • therapeutics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

44 pages, 8939 KiB  
Review
The Impact of HIV on Early Brain Aging—A Pathophysiological (Re)View
by Mihai Lazar, Ruxandra Moroti, Ecaterina Constanta Barbu, Cristina Emilia Chitu-Tisu, Catalin Tiliscan, Teodora Maria Erculescu, Ruxandra Raluca Rosca, Stefan Frasila, Emma Teodora Schmilevschi, Vladimir Simion, George Theodor Duca, Isabela Felicia Padiu, Darie Ioan Andreescu, Andreea Nicoleta Anton, Cosmina Georgiana Pacurar, Patricia Maria Perdun, Alexandru Mihai Petre, Constantin Adrian Oprea, Adelina Maria Popescu, Enachiuc Maria, Daniela Adriana Ion and Mihaela Cristina Olariuadd Show full author list remove Hide full author list
J. Clin. Med. 2024, 13(23), 7031; https://doi.org/10.3390/jcm13237031 - 21 Nov 2024
Viewed by 1483
Abstract
Background/Objectives: This review aims to provide a comprehensive understanding of how HIV alters normal aging trajectories in the brain, presenting the HIV-related molecular mechanisms and pathophysiological pathways involved in brain aging. The review explores the roles of inflammation, oxidative stress, and viral [...] Read more.
Background/Objectives: This review aims to provide a comprehensive understanding of how HIV alters normal aging trajectories in the brain, presenting the HIV-related molecular mechanisms and pathophysiological pathways involved in brain aging. The review explores the roles of inflammation, oxidative stress, and viral persistence in the brain, highlighting how these factors contribute to neuronal damage and cognitive impairment and accelerate normal brain aging. Additionally, it also addresses the impact of antiretroviral therapy on brain aging and the biological markers associated with its occurrence. Methods: We extensively searched PubMed for English-language articles published from 2000 to 2024. The following keywords were used in the search: “HIV”, “brain”, “brain aging”, “neuroinflammation”, “HAART”, and “HAND”. This strategy yielded 250 articles for inclusion in our review. Results: A combination of blood-brain barrier dysfunction, with the direct effects of HIV on the central nervous system, chronic neuroinflammation, telomere shortening, neurogenesis impairments, and neurotoxicity associated with antiretroviral treatment (ART), alters and amplifies the mechanisms of normal brain aging. Conclusions: Current evidence suggests that HIV infection accelerates neurodegenerative processes of normal brain aging, leading to cognitive decline and structural brain changes at an earlier age than typically observed in the general population. Full article
(This article belongs to the Special Issue Clinical Role of Neuroinflammation in Disease)
Show Figures

Figure 1

Back to TopTop